PMID- 23154241 OWN - NLM STAT- MEDLINE DCOM- 20130221 LR - 20181202 IS - 1879-0631 (Electronic) IS - 0024-3205 (Linking) VI - 92 IP - 1 DP - 2013 Jan 17 TI - Endoplasmic reticulum stress in HepG2 cells inhibits apolipoprotein A-I secretion. PG - 72-80 LID - S0024-3205(12)00659-5 [pii] LID - 10.1016/j.lfs.2012.11.001 [doi] AB - AIMS: Endoplasmic reticulum (ER) stress modulates gene expression and has been implicated in causing dyslipidemias. To determine if ER stress may contribute to hypoalphalipoproteinemia through suppression of apo A-I gene expression, human hepatoma cell line Hep G2 was treated with ER stress inducers and the changes in apo A-I gene expression were compared to albumin gene expression. MAIN METHODS: HepG2 cells were treated with tunicamycin (TM) and thapsigargin (TG), two potent inducers of ER stress, and apo A-I and albumin protein levels, mRNA levels, and promoter activity were measured. ER stress was measured using the ER stress-responsive alkaline phosphatase assay and by Western blot quantitation of ER stress markers such as glucose-regulated protein-78 (GRP-78), phosphorylated Jun N-terminal kinase (phospho-JNK), total JNK, phosphorylated eukaryotic initiation factor 2 alpha (phospho eIF2alpha), and total eIF2alpha. KEY FINDINGS: TM and TG induced ER stress in HepG2 cells and reduced apo A-I and albumin secretion in a dose-dependent manner. Intracellular albumin levels increased in cells treated with TM and TG while intracellular apo A-I levels decreased. Albumin mRNA and albumin gene promoter activity were reduced in proportion to the decrease in albumin secreted while changes in the apo A-I mRNA levels and promoter activity were modest and did not account for the reduction in apo A-I secretion. SIGNIFICANCE: These results indicate that apo A-I secretion is inhibited by ER stress possibly by affecting cellular degradation pathways. However, ER stress does not affect apo A-I secretion by regulating gene expression. CI - Copyright (c) 2012 Elsevier Inc. All rights reserved. FAU - Naem, Emad AU - Naem E AD - The Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Florida, Jacksonville College of Medicine, Jacksonville, FL 32209, USA. FAU - Haas, Michael J AU - Haas MJ FAU - Wong, Norman C W AU - Wong NC FAU - Mooradian, Arshag D AU - Mooradian AD LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20121112 PL - Netherlands TA - Life Sci JT - Life sciences JID - 0375521 RN - 0 (Albumins) RN - 0 (Apolipoprotein A-I) RN - 0 (Biomarkers) RN - 0 (RNA, Messenger) RN - 11089-65-9 (Tunicamycin) RN - 67526-95-8 (Thapsigargin) SB - IM MH - Albumins/genetics/metabolism MH - Apolipoprotein A-I/genetics/*metabolism MH - Biomarkers/metabolism MH - Blotting, Western MH - Dose-Response Relationship, Drug MH - Endoplasmic Reticulum Stress/*drug effects MH - Gene Expression Regulation/*drug effects MH - Hep G2 Cells MH - Humans MH - Promoter Regions, Genetic/genetics MH - RNA, Messenger/metabolism MH - Thapsigargin/administration & dosage/*pharmacology MH - Tunicamycin/administration & dosage/*pharmacology EDAT- 2012/11/17 06:00 MHDA- 2013/02/22 06:00 CRDT- 2012/11/17 06:00 PHST- 2012/08/21 00:00 [received] PHST- 2012/10/03 00:00 [revised] PHST- 2012/10/30 00:00 [accepted] PHST- 2012/11/17 06:00 [entrez] PHST- 2012/11/17 06:00 [pubmed] PHST- 2013/02/22 06:00 [medline] AID - S0024-3205(12)00659-5 [pii] AID - 10.1016/j.lfs.2012.11.001 [doi] PST - ppublish SO - Life Sci. 2013 Jan 17;92(1):72-80. doi: 10.1016/j.lfs.2012.11.001. Epub 2012 Nov 12.